Share

COVID-19 Infection Linked to Relapse of Rare Endocrine Disorder After 19 Years

A rare case study published in JCEM Case Reports details the first known instance of a decades-dormant hormonal disorder, Cyclic Cushing Syndrome (CS), relapsing after a patient contracted COVID-19 and received standard glucocorticoid treatment. The relapse occurred after a remarkable 19-year period of remission, leading researchers to suggest that the stress of the infection and...
Share

Remembering Joel Habener, MD

Habener, Joel The world of endocrinology – and indeed the world – lost a titan at the end of 2025 in Joel Habener, MD, who passed away December 28 at the age of 88. Habener, a professor of medicine at Harvard Medical School and director of the Laboratory of Molecular Endocrinology at Massachusetts General Hospital in Boston,...
Share

Pharma Friday – January 9, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism On January 7, Rezolute, Inc., a late-stage rare disease company focused on treating hypoglycemia caused by all forms...
Share

Meet the 2026 Laureates

The Endocrine Society is proud of its many distinguished members who lead the global endocrine community by advancing scientific knowledge, providing exemplary care, teaching the next generation of endocrinologists, and improving human health worldwide. For more than 80 years, the Society has recognized the achievements of its members with the annual Laurate Awards. Established in...
Share

New Directions in Thyroid Care: Minimizing Risk, Maximizing Choice

EN january 2026 cover From how radioiodine therapy for Graves’ disease impacts cancer occurrence and the potential usefulness of pharmacologic treatment for benign thyroid nodules to how a minimally invasive procedure could be the preferred treatment option, recent studies from The Journal of Clinical Endocrinology & Metabolism further demonstrate how endocrine science is benefiting patients around the world. As...
Share

Newell-Price Named Clinical Research Director at Sheffield Teaching Hospitals NHS Foundation Trust

John Newell-Price, MD, PhD, FRCP, professor of endocrinology at the University of Sheffield, honorary consultant physician at Sheffield Teaching Hospitals NHS Foundation Trust, and past-president of the Endocrine Society, has been appointed as the new Clinical Research Director at Sheffield Teaching Hospitals NHS Foundation Trust. Newell-Price’s clinical expertise includes pituitary and adrenal disorders, genetic endocrine...